Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy

Xie, Shaobing; Qiang, Qingfen; Mei, Lingyun; He, Chufeng; Sun, Huawei; Wu, Xuewen

doi:10.1007/s00405-017-4784-4

Cited by 34 publications

(21 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Xie et al showed that in patients who recovered from hearing loss, HBOT was initiated on average 5.6 days after onset of symptoms, whereas the non-recovered patients were treated on average after 9.1 days ( P = 0.003) [ 120 ].…”

Section: Clinical Use Of Hyperbaric Oxygen Therapymentioning

confidence: 99%

The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review

Bayoumy

2019

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Introduction Acute hearing loss can have a major impact on a patient’s life. This holds true for both acute acoustic trauma (AAT) and idiopathic sudden sensorineural hearing loss (ISSHL), two devastating conditions for which no highly effective treatment options exist. This narrative review provides the rationale and evidence for HBOT in AAT and ISSHL. Methods Narrative review of all the literature available on HBOT in acute hearing loss, studies were retrieved from systematic searches on PubMed and by cross referencing. Discussion First, the etiological mechanisms of acute hearing loss and the mechanism of action of HBOT were discussed. Furthermore, we have provided an overview of 68 studies that clinically investigated the effect of HBOT in the last couple of decades. For future studies, it is recommend to start as early as possible with therapy, preferably within 48 h and to use combination therapy consisting of HBOT and corticosteroids. Implications for practice HBOT has been used quite extensively for acute hearing loss in the last couple of decades. Based on the amount of studies showing a positive effect, HBOT should be discussed with patients (shared decision making) as optional therapy in case of AAT and ISSHL.

show abstract

Section: Clinical Use Of Hyperbaric Oxygen Therapymentioning

confidence: 99%

The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review

Bayoumy

2019

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…Various prognostic factors have been assessed to predict recovery from SSNHL, including age, onset of hearing loss, initial hearing loss, types of audiogram, accompanying symptoms, therapeutic method, and systemic diseases, such as diabetes mellitus and hypertension. 22,24,43 However, there is no relevant case series research on the prognosis of SSNHL during pregnancy. According to previous studies (Table 1), most pregnant patients with SSNHL achieved complete or partial recovery after treatment according to Siegel's criteria.…”

Section: Prognosismentioning

confidence: 99%

Clinical management and progress in sudden sensorineural hearing loss during pregnancy

Xie

2019

J Int Med Res

Self Cite

View full text Add to dashboard Cite

Sudden sensorineural hearing loss (SSNHL) is a relatively rare, but distressing, disease in pregnant women. Little is known about the causes, clinical manifestations, treatments, and prognosis of SSNHL. Some hypotheses have been proposed to explain the pathophysiological mechanism of SSNHL, but most of them have not been identified. This article reviews the existing literature to present a summary of this clinical problem. Most patients suffer from SSNHL in the second or third trimester, and show moderate to profound hearing loss. The interval between the initial treatment and onset of hearing loss is less than 10 days in most patients. Some patients with SSNHL show tinnitus, vertigo, or dizziness, and fullness of the ear. Although some patients have a tendency for self-cure, treatment with intravenous dextran 40 combined with intratympanic corticosteroids is probably a safe and effective therapeutic strategy for pregnant patients with SSNHL. Further clinical research is necessary to identify the best therapeutic strategy for these patients.

show abstract

“…The pattern of the audiogram was categorized into four types according to previous studies: ascending, descending, flat, and profound. 2,15…”

Section: Audiologic Evaluation and Recovery Assessmentmentioning

confidence: 99%

“…The initial hearing threshold was a widely debated prognostic factor of SSNHL. 2,15,26,27 Most researchers believed that a higher initial hearing threshold was an indicator of a poor prognosis in SSNHL patient, 2,15,26 but some studies failed to observe an association between initial hearing threshold and hearing improvement. 28 Moreover, Lin et al 21 said that comparisons between those reports must be treated with caution because of different recovery evaluation criteria.…”

Section: Effect Of the Initial Hearing Threshold On Hearing Recoverymentioning

confidence: 99%

“…In our study, our results showed higher initial hearing threshold was significantly correlated with a poor prognosis by both Siegel's criteria and CMAO criteria which was in accord with most previous reports. 2,15,26 It is believed that the extent cochlear hair cells injury was more extensive in SSNHL patients with higher initial hearing thresholds, and it is more difficult to achieve a significant structural and functional recovery after treatment. 2,15…”

Section: Effect Of the Initial Hearing Threshold On Hearing Recoverymentioning

confidence: 99%

See 1 more Smart Citation

Effect of systemic lupus erythematosus and rheumatoid arthritis on sudden sensorineural hearing loss

Xie

Ning

She³

et al. 2019

The Laryngoscope

Self Cite

View full text Add to dashboard Cite

Objectives Recent reports have identified autoimmune systemic diseases as a significant risk factor for sudden sensorineural hearing loss (SSNHL). We investigated whether systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) were correlated with the hearing recovery of SSNHL. Study Design A retrospective study. Methods Records of 663 SSNHL patients between January 2008 and January 2019 were retrospectively reviewed, including demographic, comorbid diseases, and hearing recovery. Patients were divided into four groups (complete, partial, slight, and no recovery) according to Siegel's criteria and Chinese Medical Association of Otolaryngology (CMAO) criteria. Multinomial logistic regression was performed to evaluate the effects of onset of treatment, initial hearing threshold, audiogram pattern, diabetes mellitus, SLE, and RA on the prognosis of SSNHL according to both criteria. Results Patients in complete recovery, partial recovery, slight recovery, and no improvement were 95 (14.3%), 183 (27.6%), 170 (25.6%), and 215 (32.4%) by Siegel's criteria, and 90 (13.6%), 152 (22.9%), 188 (28.4%), and 233 (35.1%) by CMAO criteria, respectively. Among the four groups, onset of treatment, initial hearing threshold, diabetes mellitus, SLE, RA, and profound audiogram pattern were found to be associated with recovery outcome by both Siegel's criteria and CMAO criteria (P < .05). According to analysis results, presence of SLE, RA, diabetes mellitus and higher initial hearing threshold were significantly correlated with a poor prognosis by both Siegel's criteria and CMAO criteria (P < .05). Conclusion Comorbid SLE or RA may negatively affect the prognosis of SSNHL. Lower initial hearing threshold and absence of diabetes mellitus are associated with favorable hearing recovery. Level of Evidence 4. Laryngoscope, 130:2475–2480, 2020

show abstract

Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy

Cited by 34 publications

References 19 publications

The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review

The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review

Clinical management and progress in sudden sensorineural hearing loss during pregnancy

Effect of systemic lupus erythematosus and rheumatoid arthritis on sudden sensorineural hearing loss

Contact Info

Product

Resources

About